HIV-1 protease-IN-4 (Compound II-22), a potent inhibitor of the HIV-1 protease, acts as a prodrug for atazanavir. It notably enhances the bioavailability of atazanavir in rat plasma, achieving a 5-fold increase in the area under the curve (AUC) and a 67-
Molecular Weight:
920.1
Formula:
C48H69N7O11
* VAT and and shipping costs not included. Errors and price changes excepted
